Gulf International Bank UK Ltd Decreases Stock Position in MetLife, Inc. (NYSE:MET)

Gulf International Bank UK Ltd cut its holdings in MetLife, Inc. (NYSE:METFree Report) by 1.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,243 shares of the financial services provider’s stock after selling 609 shares during the quarter. Gulf International Bank UK Ltd’s holdings in MetLife were worth $3,704,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. United Asset Strategies Inc. boosted its position in shares of MetLife by 1.1% during the fourth quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider’s stock valued at $895,000 after buying an additional 120 shares during the last quarter. Barrett & Company Inc. grew its stake in shares of MetLife by 1.0% in the fourth quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider’s stock worth $978,000 after acquiring an additional 121 shares during the period. Great Valley Advisor Group Inc. raised its holdings in shares of MetLife by 1.3% during the third quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider’s stock valued at $781,000 after purchasing an additional 123 shares during the last quarter. J.W. Cole Advisors Inc. lifted its position in MetLife by 2.1% during the fourth quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider’s stock valued at $495,000 after purchasing an additional 126 shares during the period. Finally, First Commonwealth Financial Corp PA lifted its position in MetLife by 0.8% during the third quarter. First Commonwealth Financial Corp PA now owns 16,675 shares of the financial services provider’s stock valued at $1,375,000 after purchasing an additional 133 shares during the period. Institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

Shares of NYSE:MET opened at $84.08 on Friday. The company has a market capitalization of $58.22 billion, a P/E ratio of 14.08, a P/E/G ratio of 0.65 and a beta of 1.07. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05. The firm’s 50 day simple moving average is $83.56 and its two-hundred day simple moving average is $81.72. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:METGet Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Research analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.59%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio is currently 36.52%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company upped their price objective on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. Keefe, Bruyette & Woods lowered their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a report on Wednesday, February 12th. Barclays cut their price target on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Finally, StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.58.

View Our Latest Report on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.